News | MRI Breast | February 07, 2017

Technique reduces breast MRI down to essential components that can be performed more quickly and affordably

breast MRI, new AB-MR exam protocol, Via Radiology, cancer detection, dense breasts, women's health

February 7, 2017 — A newly developed breast magnetic resonance imaging (MRI) exam protocol, the first of its kind being offered in the Pacific Northwest, is now being performed at Via Radiology in north Seattle.

Fifty percent of women over the age of 40 have dense breast tissue, which significantly reduces the ability to detect cancer on mammograms. MRI is a powerful tool in its ability to detect early breast cancer and is not affected by dense breast tissue. However, due to its high cost, breast MRI has until now only been recommended for screening women who are at high risk.

Via Radiology’s Abbreviated Breast MRI (AB-MR) protocol distills traditional breast MRI to its essential components that can then be performed more quickly and affordably compared with traditional breast MRI. Studies have shown that this new protocol is equivalent in accuracy to the traditional exam.

On average, mammograms detect four to five cancers per 1,000 women screened, whereas breast MRI detects 16-23 more cancers per 1,000 women screened, according to Via Radiology CEO Craig Hanson, M.D. He added that the lower end of that range comes in women who are at average risk of getting breast cancer.

The sensitivity of mammography in dense-breasted women is only 38 percent, meaning up to 62 percent of cancers may go undetected until they are discovered as a palpable lump. As a result, there is an excess of late-stage disease and mortality in these women.

Hanson added that breast ultrasound only detects two to three more cancers per 1,000 average-risked women screened, and at the cost of a high false positive rate, meaning lots of unnecessary biopsies.

While there have been major advances in breast cancer treatment, the stage at the time of diagnosis remains the most important factor in survival. Finding a breast cancer early also means less debilitating and costly treatment.

At less than $500, AB-MR now provides a viable, highly accurate alternative method for screening women at any risk, especially those with dense breast tissue.

For more information: www.viaradiology.com


Related Content

Feature | Uzay Emir and Stephen Sawiak

Healthcare has reached a critical juncture. The World Economic Forum estimates that global medical costs will see double ...

Time December 04, 2025
arrow
News | Breast Imaging

Dec. 01, 2025 — DeepHealth, a wholly owned subsidiary of RadNet, Inc., has launched the DeepHealth Breast Suite,2 an end ...

Time December 04, 2025
arrow
News | Women's Health

Dec. 1, 2025 — ScreenPoint Medical has completed a commercial agreement making its Transpara breast-imaging AI portfolio ...

Time December 03, 2025
arrow
News | Mammography

Nov. 30, 2025 — At RSNA 2025, Siemens Healthineers will introduce new capabilities for its Mammomat B.brilliant ...

Time December 02, 2025
arrow
News | RSNA 2025

Dec. 2, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, will present 14 studies at RSNA ...

Time December 02, 2025
arrow
News | Women's Health

Dec. 1, 2025 — A study of data from seven outpatient facilities in the New York region found that 20-24% of all the ...

Time December 02, 2025
arrow
News | Mammography

Nov. 26, 2025 — GE HealthCare has announced it received FDA Premarket Authorization for Pristina Recon DL, an advanced ...

Time November 29, 2025
arrow
News | Artificial Intelligence

Nov. 25, 2025 – Medical imaging AI company Avicenna.AI has announced a strategic partnership with Ferrum, an AI ...

Time November 25, 2025
arrow
News | Advanced Visualization

Nov. 20, 2025 — Avatar Medical and Barco have launched Eonis Vision, marking a new evolution in how medical imaging is ...

Time November 20, 2025
arrow
News | Ultrasound Imaging

Nov. 12, 2025 — GE HealthCare and DeepHealth, Inc., a wholly owned subsidiary of RadNet, Inc., have announced their ...

Time November 20, 2025
arrow
Subscribe Now